Knowledge, Perceptions, and Practice of Nurses on Surveillance of Adverse Events following Childhood Immunization in Nairobi, Kenya
Table 2
Knowledge levels of respondents on AEFI surveillance.
Aspects of knowledge on AEFI surveillance,
Freq.
%
AEFI as a medical condition is not limited to vaccination only
73
27.8
AEFI can be caused by reconstituted vaccine stored longer than the recommended period; vaccine reaction; inappropriate route or injection technique; vaccines stored beyond expiry date; or contaminated vaccine diluents
102
37.6
Skin at injection site should be stretched during IM injections
99
36.5
Paracetamol and ibuprofen are not used routinely to prevent immunization fever
136
49.6
DHMT is responsible for supervising facilities on AEFI
129
37.8
Adrenaline should not be administered subcutaneously during anaphylaxis
61
22.5
During anaphylaxis, patient’s legs are raised above trunk and given oxygen
108
39.4
DPHN receives AEFI reports from facility nurse
163
60.1
AEFI investigation examines operational aspects of the program
99
36.4
Investigation of an AEFI should be commenced within 24 hrs
69
25.5
All injection site abscesses should be reported
28
10.3
Injection site swelling and redness should be reported
22
8.3
Treatment of a coincidental illness falsely attributed as a vaccine reaction should not be delayed until investigations are confirmed
69
25.7
Immunization surveillance aims at early detection and response to AEFI
